News & Press Releases
Stay up to date about interesting developments, news and press releases from Saillant Therapeutics.
Persbericht: Saillant Therapeutics rapporteert proof of concept in de behandeling van hartfalen
Saillant Therapeutics meldt succes in preklinisch onderzoek bij de behandeling van hartfalen, met herstel van functie en zelfs regeneratie van de hartspier Nijmegen, 4 november, 2020 -- Saillant Therapeutics, een biotechnologiebedrijf in de preklinische fase dat...
Press Release: Saillant Therapeutics reports proof of concept in heart failure treatment
Saillant Therapeutics Reports Proof of Concept of its Treatment in Heart Failure showing Functional Reversal and Myocardial Rejuvenation Nijmegen, The Netherlands, 4 November, 2020 -- Saillant Therapeutics, an innovative preclinical stage biotechnology company...
Press Release: Saillant Therapeutics to develop generic virus inhibiting therapy
Dutch Saillant Therapeutics to develop generic virus inhibiting therapy based on activation of a cellular master regulator, ending virus replication Nijmegen, The Netherlands, 11 August 2020 -- Saillant Therapeutics, an innovative biotechnology start-up, developing...
Ready to Make a Change?
By our full preclinical package, we will work together with you throughout the process until the commercialization of your drug candidate.